Publications

Export 34 results:
Auteur Title [ Type(Asc)] Année
Filtres: Auteur is Cecilia Flores  [Enlever les filtres]
Journal Article
Manitt C, Eng C, Pokinko M, Ryan RT, Torres-Berrío A, Lopez JP, Yogendran SV, Daubaras MJJ, Grant A, Schmidt ERE et al..  2013.  dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients.. Transl Psychiatry. 3:e338.
Reynolds LM, Gifuni AJ, E McCrea T, Shizgal P, Flores C.  2016.  dcc Haploinsufficiency results in blunted sensitivity to cocaine enhancement of reward seeking.. Behav Brain Res. 298(Pt A):27-31.
Pokinko M, Grant A, Shahabi F, Dumont Y, Manitt C, Flores C.  2017.  Dcc haploinsufficiency regulates dopamine receptor expression across postnatal lifespan.. Neuroscience. 346:182-189.
Torres-Berrío A, Lopez JPablo, Bagot RC, Nouel D, Dal Bo G, Cuesta S, Zhu L, Manitt C, Eng C, Cooper HM et al..  2017.  DCC Confers Susceptibility to Depression-like Behaviors in Humans and Mice and Is Regulated by miR-218.. Biol Psychiatry. 81(4):306-315.
Grant A, Fathalli F, Rouleau G, Joober R, Flores C.  2012.  Association between schizophrenia and genetic variation in DCC: a case-control study.. Schizophr Res. 137(1-3):26-31.
Reynolds LM, Makowski CS, Yogendran SV, Kiessling S, Cermakian N, Flores C.  2015.  Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent manner.. Neuropsychopharmacology. 40(5):1101-12.
Walker DM, Bell MR, Flores C, Gulley JM, Willing J, Paul MJ.  2017.  Adolescence and Reward: Making Sense of Neural and Behavioral Changes Amid the Chaos.. J Neurosci. 37(45):10855-10866.
Yetnikoff L, Pokinko M, Arvanitogiannis A, Flores C.  2014.  Adolescence: a time of transition for the phenotype of dcc heterozygous mice.. Psychopharmacology (Berl). 231(8):1705-14.
Yetnikoff L, Almey A, Arvanitogiannis A, Flores C.  2011.  Abolition of the behavioral phenotype of adult netrin-1 receptor deficient mice by exposure to amphetamine during the juvenile period.. Psychopharmacology (Berl). 217(4):505-14.

Pages